Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the porto pediatric IBD group.
de Ridder L, Turner D, Wilson DC, Koletzko S, Martin-de-Carpi J, Fagerberg UL, Spray C, Sladek M, Shaoul R, Roma-Giannikou E, Bronsky J, Serban DE, Cucchiara S, Veres G, Ruemmele FM, Hojsak I, Kolho KL, Davies IH, Aloi M, Lionetti P, Veereman-Wauters G, Braegger CP, Trindade E, Wewer AV, Hauer A, Levine A; Porto IBD Working Group of ESPGHAN. de Ridder L, et al. Inflamm Bowel Dis. 2014 Feb;20(2):291-300. doi: 10.1097/01.MIB.0000439066.69340.3c. Inflamm Bowel Dis. 2014. PMID: 24374875 Free article.
Phenotype and disease course of early-onset pediatric inflammatory bowel disease.
Aloi M, Lionetti P, Barabino A, Guariso G, Costa S, Fontana M, Romano C, Lombardi G, Miele E, Alvisi P, Diaferia P, Baldi M, Romagnoli V, Gasparetto M, Di Paola M, Muraca M, Pellegrino S, Cucchiara S, Martelossi S; SIGENP IBD Group. Aloi M, et al. Among authors: alvisi p. Inflamm Bowel Dis. 2014 Apr;20(4):597-605. doi: 10.1097/01.MIB.0000442921.77945.09. Inflamm Bowel Dis. 2014. PMID: 24569242
Natural history of pancreatic involvement in paediatric inflammatory bowel disease.
Martinelli M, Strisciuglio C, Illiceto MT, Cardile S, Guariso G, Vignola S, Aloi M, D'Altilia MR, Alvisi P, Salvatore S, Staiano A, Cucchiara S, Miele E; IMIBD Group of the Italian Society for Paediatric Gastroenterology, Hepatology and Nutrition. Martinelli M, et al. Among authors: alvisi p. Dig Liver Dis. 2015 May;47(5):384-9. doi: 10.1016/j.dld.2015.01.155. Epub 2015 Feb 3. Dig Liver Dis. 2015. PMID: 25704068
Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry.
Aloi M, Bramuzzo M, Arrigo S, Romano C, D'Arcangelo G, Lacorte D, Gatti S, Illiceto MT, Zucconi F, Dilillo D, Zuin G, Knafelz D, Ravelli A, Cucchiara S, Alvisi P; SIGENP IBD Working Group. Aloi M, et al. Among authors: alvisi p. J Pediatr Gastroenterol Nutr. 2018 Jun;66(6):920-925. doi: 10.1097/MPG.0000000000001883. J Pediatr Gastroenterol Nutr. 2018. PMID: 29315163
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study.
Naviglio S, Lacorte D, Lucafò M, Cifù A, Favretto D, Cuzzoni E, Silvestri T, Pozzi Mucelli M, Radillo O, Decorti G, Fabris M, Bramuzzo M, Taddio A, Stocco G, Alvisi P, Ventura A, Martelossi S. Naviglio S, et al. Among authors: alvisi p. J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):37-44. doi: 10.1097/MPG.0000000000002112. J Pediatr Gastroenterol Nutr. 2019. PMID: 30211845 Free article.
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience.
Alvisi P, Arrigo S, Cucchiara S, Lionetti P, Miele E, Romano C, Ravelli A, Knafelz D, Martelossi S, Guariso G, Accomando S, Zuin G, De Giacomo C, Balzani L, Gennari M, Aloi M; SIGENP IBD Working Group. Alvisi P, et al. Biologics. 2019 Jan 3;13:13-21. doi: 10.2147/BTT.S183088. eCollection 2019. Biologics. 2019. PMID: 30655661 Free PMC article.
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).
Fiorino G, Caprioli F, Daperno M, Mocciaro F, Principi M, Viscido A, Fantini MC, Orlando A, Papi C, Annese V, Danese S, Vecchi M, Rizzello F, Armuzzi A; National patients’ association representatives. Fiorino G, et al. Dig Liver Dis. 2019 May;51(5):632-639. doi: 10.1016/j.dld.2019.02.004. Epub 2019 Feb 19. Dig Liver Dis. 2019. PMID: 30872085 Review.
Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study.
Bramuzzo M, Arrigo S, Romano C, Filardi MC, Lionetti P, Agrusti A, Dipasquale V, Paci M, Zuin G, Aloi M, Strisciuglio C, Miele E, Pastore M, Martelossi S, Alvisi P; SIGENP IBD Working Group. Bramuzzo M, et al. Among authors: alvisi p. United European Gastroenterol J. 2019 Jul;7(6):759-766. doi: 10.1177/2050640619847592. Epub 2019 Apr 25. United European Gastroenterol J. 2019. PMID: 31316780 Free PMC article.
85 results